Nuance Health Introduces New Product Designed to Enhance Defense Against Colds and Flu

Article

Nuance Health, LLC, a company that develops products designed to help people maintain good health, today introduced Swype, a new product that enhances defense against viruses at the body's most vulnerable spot the nose. In independent lab studies, the ingredients in Swype killed more than 99.9 percent of 25 viruses that cause colds and flu. Dr. Kent New, a physician with a PhD in immunology and microbiology, developed Swype to help stop the spread of illness in his young family.

"My goal when creating Swype was to develop a gel that was tough on viruses while being gentle on the skin. And since Swype is applied to the entrance to the nose, I knew people would want it to be invisible," New says. "I used as many natural ingredients as possible, as long as they were proven safe and effective. And I made sure to avoid zinc and alcohol since there are reports that they are potentially toxic to the nose and airways."

New came up with the idea for Swype by using his knowledge that viruses typically spread through hand-to-hand contact, and make you sick when they enter your body through your mouth, eyes, and especially your nose.

"Swype worked so well for my family that I decided to make more in order to share it with friends. As requests for Swype increased, my wife and I decided to start Nuance Health so we could provide Swype to more people and spread the benefits of good health," New adds.

Swype is available on the Swype website (www.SwypeForHealth.com). A tube that lasts approximately 2 months costs $12.99. However, for a limited time Nuance Health is offering a two-for-one discount to people who serve in their community, such as teachers, police officers and firefighters. To receive the discount, send an email to GivingBack@NuanceHealth.com that includes your city, state, and a brief description of your service role.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content